A randomized trial of colchicine for acute pericarditis

Basit Öğe Kaydı
dc.contributor.authorKaraaslan, Yaşar
dc.contributor.authorŞimşek, İsmail
dc.date.accessioned2019-05-10T09:39:11Z
dc.date.available2019-05-10T09:39:11Z
dc.date.issued2014
dc.departmentHitit Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
dc.description.abstractTo the Editor: With regard to the use of colchicine to prevent recurrent pericarditis, Imazio et al. (Oct. 17 issue)(1) might have achieved an even more favorable outcome in their study if they had used a dose of colchicine higher than 0.5 mg per deciliter for patients weighing less than 70 kg. I routinely treat patients with familial Mediterranean fever with 1.2 mg per deciliter regardless of their weight. Of approximately 40 such patients followed for many years while taking colchicine daily, none have reported side effects other than mild and easily managed diarrhea, which occurred in a few.
dc.identifier.citationKaraaslan, Y., & Simsek, I. (2014). A randomized trial of colchicine for acute pericarditis. The New England journal of medicine, 370 8, 780-1 .
dc.identifier.doi10.1056/NEJMc1315351
dc.identifier.endpage781en_US
dc.identifier.issn0028-4793
dc.identifier.issue8en_US
dc.identifier.scopusqualityQ1
dc.identifier.startpage780en_US
dc.identifier.urihttps://doi.org/10.1056/NEJMc1315351
dc.identifier.urihttps://hdl.handle.net/11491/627
dc.identifier.volume370en_US
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherMassachussetts Medical Society
dc.relation.ispartofNew England Journal of Medicine
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subject[Belirlenecek]en_US
dc.titleA randomized trial of colchicine for acute pericarditis
dc.typeOther

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
Diğer Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu